Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations. [electronic resource]
Producer: 20010607Description: 2754-63 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Alitretinoin
- Antigens, Nuclear
- Antineoplastic Agents -- adverse effects
- Area Under Curve
- Biomarkers
- Breast Neoplasms -- drug therapy
- Cholesterol -- blood
- Chromatography, High Pressure Liquid
- Female
- Humans
- Ki-67 Antigen
- Middle Aged
- Nuclear Proteins -- isolation & purification
- Tamoxifen -- therapeutic use
- Tretinoin -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.